Cargando…
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?
Leiomyosarcoma is one of the most common subtypes of soft tissue sarcomas accounting for approximately 20% of sarcomas. As leiomyosarcoma patients frequently develop metastatic disease, effective systemic therapies are needed to improve clinical outcomes. The overall activity of the currently availa...
Autores principales: | Kasper, Bernd, D’Ambrosio, Lorenzo, Davis, Elizabeth J., Ingham, Matthew, Broto, Javier Martin, Trent, Jonathan C., van Houdt, Winan J., Van Tine, Brian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930904/ https://www.ncbi.nlm.nih.gov/pubmed/35275323 http://dx.doi.org/10.1007/s11864-021-00928-y |
Ejemplares similares
-
New Systemic Therapy Options for Advanced Sarcomas
por: van der Graaf, Winette T. A., et al.
Publicado: (2012) -
Systemic Treatment for Adults with Synovial Sarcoma
por: Desar, Ingrid M. E., et al.
Publicado: (2018) -
Phase III Soft Tissue Sarcoma Trials: Success or Failure?
por: Lee, Alexander T. J., et al.
Publicado: (2017) -
Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates: Revolutions in treatment options in GIST
por: Farag, Sheima, et al.
Publicado: (2020) -
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives
por: Fiore, Michele, et al.
Publicado: (2021)